Uncertainty of prognosis is one reason patients with hematologic malignancies receive aggressive therapy near end of life more often than those with advanced solid tumors. It is unknown whether end-of ...
Observational cohort study of cancer decedents between 2007 and 2009. Decedents required ≥1 ESAS or PPS assessment in the 6 months before death for inclusion. Outcomes were the decedents' average ESAS ...
“Because many traditional interventions for HF, such as diuresis and inotropy, often improve symptoms, practitioners managing patients with HF, may not think that PC consultation is necessary,” wrote ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback